Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Revenue

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹31,724 Cr₹29,002 Cr₹24,855 Cr₹23,455 Cr₹24,775 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹31,724 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹31,724 Cr
Mar2024₹29,002 Cr
Mar2023₹24,855 Cr
Mar2022₹23,455 Cr
Mar2021₹24,775 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹31,724 Cr
9.39
Mar2024 ₹29,002 Cr
16.68
Mar2023 ₹24,855 Cr
5.97
Mar2022 ₹23,455 Cr
-5.32
Mar2021 ₹24,775 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹60,417.7 Cr 1.9% -3% -32.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹379,191.0 Cr 1% -0.9% -13% Stock Analytics
DIVIS LABORATORIES ₹159,973.0 Cr -1.6% -1.8% 17.9% Stock Analytics
CIPLA ₹124,507.0 Cr -1.8% 3.7% -6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,175.0 Cr 0.7% 2.4% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,355.0 Cr -0.6% 4.5% -6.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.9%

-3%

-32.6%

SENSEX

0.5%

0.1%

-2.1%


You may also like the below Video Courses